Literature DB >> 15592136

The cognitive subscale of Alzheimer's Disease Assessment Scale, Chinese version in staging of Alzheimer disease.

Huali Wang1, Xin Yu, Shuran Li, Yufang Chen, Haidong Li, Jun He.   

Abstract

This study was designed to examine the utility of the ADAS-Cog, Chinese version (ADAS-Cog-C) for staging of dementia in Alzheimer disease (AD). A total of 305 patients with AD (199 mild AD and 106 moderate AD) meeting the NINCDS-ADRDA criteria of probable AD were recruited. The ADAS-Cog-C was administered to all AD subjects. The total score of ADAS-Cog-C and each item score differed significantly between mild and moderate AD groups, with moderate AD group scoring higher. Statistical analysis showed insignificant influence of age or educational level on the ADAS-Cog-C total score. The item score of orientation and constructional praxis and the ADAS-Cog total score could classify mild and moderate AD efficiently, with a sensitivity of 78% to 82% and a specificity of 70% to 73%. The results of this study indicate that the ADAS-Cog-C can discriminate mild AD from moderate AD efficiently and be useful for staging of AD. It is recommended that the ADAS-Cog-C be introduced for monitoring the cognitive efficacy in AD drug treatment among Chinese AD patients.

Entities:  

Mesh:

Year:  2004        PMID: 15592136

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  6 in total

1.  Norms for CERAD constructional praxis recall.

Authors:  Gerda G Fillenbaum; Bruce M Burchett; Frederick W Unverzagt; Daniel F Rexroth; Kathleen Welsh-Bohmer
Journal:  Clin Neuropsychol       Date:  2011-10-13       Impact factor: 3.535

2.  Globalization of Alzheimer's disease clinical trials.

Authors:  Jeffrey Cummings; Robert Reynders; Kate Zhong
Journal:  Alzheimers Res Ther       Date:  2011-08-17       Impact factor: 6.982

3.  Cognitive impairment and all-cause mortality among Chinese adults aged 80 years or older.

Authors:  Yaxi Li; Heng Jiang; Xurui Jin; Huali Wang; John S Ji; Lijing L Yan
Journal:  Brain Behav       Date:  2021-09-07       Impact factor: 2.708

4.  Effect of acupuncture with donepezil based on syndrome differentiation on cognitive function in patients with mild-to-moderate Alzheimer's disease: a study protocol for a multicenter randomized controlled trial.

Authors:  Qin-Hui Fu; Jian Pei; Hou-Guang Zhou; Tao Wang; Yi-Jun Zhan; Lin Tao; Jia Xu; Qian Zhou; Liao-Yao Wang
Journal:  Trials       Date:  2022-08-19       Impact factor: 2.728

5.  Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease.

Authors:  Xue Meng; Tao Li; Xiao Wang; Xiaozhen Lv; Zhiyu Sun; Jichun Zhang; Feng Su; Sungmin Kang; SangYun Kim; Seong Soo A An; Xin Yu; Chen Zhang; Huali Wang
Journal:  Alzheimers Res Ther       Date:  2019-10-25       Impact factor: 6.982

Review 6.  Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project.

Authors:  Huali Wang; Zili Fan; Chuan Shi; Lingchuan Xiong; Haifeng Zhang; Tao Li; Yongan Sun; Qihao Guo; Yanghua Tian; Qiumin Qu; Nan Zhang; Zaohuo Cheng; Liyong Wu; Daxing Wu; Zaizhu Han; Jinzhou Tian; Hengge Xie; Shuping Tan; Jingfang Gao; Benyan Luo; Xiaoping Pan; Guoping Peng; Bin Qin; Yi Tang; Kai Wang; Tao Wang; Junjian Zhang; Qianhua Zhao; Serge Gauthier; Xin Yu
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.